Angiogenesis inhibitors are potent anticancer drugs thought to lack acquired drug resistance problems because they target the normal endothelial cells of the tumor vasculature. But, in February 22 ...
Tom Smith works for Sheffield Hallam University. He receives funding from the Engineering and Physical Sciences Research Council. He is a member of the Labour Party. This article contains his personal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results